Canada Trumps USA: Approves Cannabis-Based Medicine

062

Canada Trumps USA: Approves Cannabis-Based Medicine. On April 19, 2005, the Canadian government gave conditional approval to prescription sale of a medicine made from extracts of marijuana plants ingested as an oral spray. It is time our officials take off their "drug war" blinders and recognize marijuana for what it is: a natural, relatively benign substance that can help bring relief to millions.

This advertisement appears in the National Review, the New Republic, the American Prospect, The Nation, Reason Magazine, and The Progressive in the summer of 2005.

Camera-ready copy of this PSA also available in Portable Document Format (PDF).

Canada Trumps USA: Approves Cannabis-Based Medicine
On April 19, 2005, the Canadian government gave conditional approval to prescription sale of a medicine made from extracts of marijuana plants ingested as an oral spray. While the US blocked privately-funded research, a British pharmaceutical company developed a cannabis extract spray that supplements existing non-smoking delivery systems such as vaporization. The risks versus the benefits of alternative methods need to be established. But the US government is obstructing the science¹ because it fears the results will demonstrate an acceptable risk/benefit ratio even for smoked marijuana. This research would be welcomed by the 14,600,000² Americans who currently use marijuana socially or medically. It is time our officials take off their "drug war" blinders and recognize marijuana for what it is: a natural, relatively benign substance that can help bring relief to millions.
Common Sense for Drug Policy www.CommonSenseDrugPolicy.org www.DrugWarFacts.org www.AddictInTheFamily.org H. Michael Gray, Chair; Robert E. Field, Co-Chair 1. For additional information, please visit www.maps.org/mmj/mmjfacility.html 2. 2003 www.drugabusestatistics.samhsa.gov/nhsda/2k3nsduh/2k3ResultsW.pdf, Page 11

Canada Trumps USA:

Approves
Cannabis-Based
Medicine

On April 19, 2005, the Canadian government gave conditional approval to prescription sale of a medicine made from extracts of marijuana plants ingested as an oral spray.

While the US blocked privately-funded research, a British pharmaceutical company developed a cannabis extract spray that supplements existing non-smoking delivery systems such as vaporization.

The risks versus the benefits of alternative methods need to be established. But the US government is obstructing the science¹ because it fears the results will demonstrate an acceptable risk/benefit ratio even for smoked marijuana.

This research would be welcomed by the 14,600,000² Americans who currently use marijuana socially or medically.

It is time our officials take off their "drug war" blinders and recognize marijuana for what it is: a natural, relatively benign substance that can help bring relief to millions.

Common Sense for Drug Policy
www.CommonSenseDrugPolicy.org www.DrugWarFacts.org
www.AddictInTheFamily.org
H. Michael Gray, Chair; Robert E. Field, Co-Chair

1. For additional information, please visit www.maps.org/mmj/mmjfacility.html
2. 2003 www.drugabusestatistics.samhsa.gov/nhsda/2k3nsduh/2k3ResultsW.pdf, Page 11

Download PDF

https://www.csdp.org/publicservice/canadatrumps.pdf